US FDA approves Stemline Therapeutics' rare blood disease treatment

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

REUTERS: The U.S. Food and Drug Administration on Friday approved Stemline Therapeutics Inc's Elzonris for the treatment of a rare blood disease ...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA approves Mylan's generic of Advair asthma treatmentREUTERS: The U.S. Food and Drug Administration (FDA) approved Mylan NV's generic version of GlaxoSmithKline-developed blockbuster asthma treatment ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Immunomedics' cancer treatment fails to win accelerated approval from the FDAREUTERS: Immunomedics Inc said on Thursday the U.S. Food and Drug Administration declined to grant accelerated approval for its breast cancer ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

FDA declines to approve Alkermes opioid-based depression drugREUTERS: The U.S. Food and Drug Administration on Friday declined to approve Alkermes Plc's opioid-based depression treatment, citing the need for ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »